Evidence map›Paper›PMID 39164292›Full record

ArticleNPJ primary care respiratory medicine2024

Uncovering patterns of inhaler technique and reliever use: the value of objective, personalized data from a digital inhaler.

Mark L Levy, Janwillem W H Kocks, Sinthia Bosnic-Anticevich, Guilherme Safioti, Michael Reich, Michael Depietro, Mario Castro, Nabeel Farooqui, Njira L Lugogo, Randall Brown and 3 more

Abstract read
In one paragraph

Article in NPJ primary care respiratory medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mark L LevyGeneral Practitioner, London, UK. bigcatdoc@gmail.com.ORCID 0000-0002-1807-3246
Janwillem W H KocksGeneral Practitioners Research Institute, Groningen, Netherlands.
Sinthia Bosnic-AnticevichWoolcock Institute of Medical Research, University of Sydney, Glebe, NSW, Australia.ORCID 0000-0001-5077-8329
Guilherme SafiotiTeva Pharmaceuticals Europe B.V., Amsterdam, Netherlands.ORCID 0000-0002-1254-5994
Michael ReichTeva Pharmaceutical Industries Ltd, Tel Aviv, Israel.
Michael DepietroTeva Branded Pharmaceutical Products R&D Inc., West Chester, PA, USA.ORCID 0000-0002-8729-2530
Mario CastroDivision of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
Nabeel FarooquiAllergy Partners of Fishers, Indianapolis, IN, USA.
Njira L LugogoDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
Randall BrownTeva Branded Pharmaceutical Products R&D Inc., West Chester, PA, USA.
Tanisha HillTeva Branded Pharmaceutical Products R&D Inc., West Chester, PA, USA.
Thomas LiTeva Branded Pharmaceutical Products R&D Inc., West Chester, PA, USA.
Henry ChrystynInhalation Consultancy Ltd, Leeds, UK.ORCID 0000-0003-1528-2146

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electronic inhalers provide information about patterns of routine inhaler use. During a 12-week study, 360 asthma patients using albuterol Digihaler generated 53,083 inhaler events that were retrospectively analyzed. A total of 41,528 (78%) of the recorded inhalation events were suitable for flow analysis (having a PIF ≥ 18 L/min and <120 L/min). Median PIF, inhalation volume, inhalation duration, and time to PIF for these events steadily decreased between the first and last 10 days of the study, by 5.1%, 12.6%, 15.9%, and 6.4%, respectively. Continuous short-acting beta

Indexed as

AsthmaNebulizers and VaporizersAdministration, InhalationAdolescentAdrenergic beta-2 Receptor AgonistsAdultAgedAlbuterolBronchodilator AgentsFemaleHumansMaleMiddle AgedRetrospective StudiesYoung AdultAdrenergic beta-2 Receptor AgonistsAlbuterolBronchodilator Agents

Identifiers

PMID39164292
PMCPMC11336086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.